Singapore markets open in 2 hours 10 minutes

Coherus BioSciences, Inc. (CHRS)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
8.65+0.17 (+2.00%)
At close: 04:00PM EST
8.48 -0.17 (-1.97%)
After hours: 05:00PM EST
Currency in USD
Earnings estimateCurrent qtr. (Dec 2022)Next qtr. (Mar 2023)Current year (2022)Next year (2023)
No. of analysts6445
Avg. Estimate-0.83-0.46-3.24-1.46
Low estimate-1.52-1-3.78-2.35
High estimate-0.58-0.23-3.03-0.84
Year ago EPS-0.46-1-1.17-3.24
Revenue estimateCurrent qtr. (Dec 2022)Next qtr. (Mar 2023)Current year (2022)Next year (2023)
No. of analysts7488
Avg. Estimate48.4M66.37M217.52M392.69M
Low estimate40.12M51M205.74M285.73M
High estimate57.99M78.6M242M515.3M
Year ago sales73.37M60.12M326.55M217.52M
Sales growth (year/est)-34.00%10.40%-33.40%80.50%
Earnings history30/12/202130/03/202229/06/202229/09/2022
Est. EPS-0.51-0.48-0.64-0.57
Actual EPS-0.46-1-0.47-0.96
Difference0.05-0.520.17-0.39
Surprise %9.80%-108.30%26.60%-68.40%
EPS trendCurrent qtr. (Dec 2022)Next qtr. (Mar 2023)Current year (2022)Next year (2023)
Current estimate-0.83-0.46-3.24-1.46
7 days ago-0.69-0.27-3.33-1.2
30 days ago-0.69-0.27-3.06-1.24
60 days ago-0.69-0.27-3.06-1.24
90 days ago-0.58-0.21-2.52-0.62
EPS revisionsCurrent qtr. (Dec 2022)Next qtr. (Mar 2023)Current year (2022)Next year (2023)
Up last 7 daysN/AN/A1N/A
Up last 30 daysN/AN/A1N/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/A1
Growth estimatesCHRSIndustrySector(s)S&P 500
Current qtr.-80.40%N/AN/AN/A
Next qtr.54.00%N/AN/AN/A
Current year-176.90%N/AN/AN/A
Next year54.90%N/AN/AN/A
Next 5 years (per annum)-25.10%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A